Guest editor's note: Practical and regulatory issues on new drug, new dosage form, and generic Drug Development
Publication
, Journal Article
hu, OYP; Chow, SC
Published in: Therapeutic Innovation & Regulatory Science
January 1, 1996
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Therapeutic Innovation & Regulatory Science
DOI
ISSN
2168-4790
Publication Date
January 1, 1996
Volume
31
Issue
4
Start / End Page
1145 / 1147
Citation
APA
Chicago
ICMJE
MLA
NLM
hu, O. Y. P., & Chow, S. C. (1996). Guest editor's note: Practical and regulatory issues on new drug, new dosage form, and generic Drug Development. Therapeutic Innovation & Regulatory Science, 31(4), 1145–1147. https://doi.org/10.1177/009286159703100411
hu, O. Y. P., and S. C. Chow. “Guest editor's note: Practical and regulatory issues on new drug, new dosage form, and generic Drug Development.” Therapeutic Innovation & Regulatory Science 31, no. 4 (January 1, 1996): 1145–47. https://doi.org/10.1177/009286159703100411.
hu OYP, Chow SC. Guest editor's note: Practical and regulatory issues on new drug, new dosage form, and generic Drug Development. Therapeutic Innovation & Regulatory Science. 1996 Jan 1;31(4):1145–7.
hu, O. Y. P., and S. C. Chow. “Guest editor's note: Practical and regulatory issues on new drug, new dosage form, and generic Drug Development.” Therapeutic Innovation & Regulatory Science, vol. 31, no. 4, Jan. 1996, pp. 1145–47. Scopus, doi:10.1177/009286159703100411.
hu OYP, Chow SC. Guest editor's note: Practical and regulatory issues on new drug, new dosage form, and generic Drug Development. Therapeutic Innovation & Regulatory Science. 1996 Jan 1;31(4):1145–1147.
Published In
Therapeutic Innovation & Regulatory Science
DOI
ISSN
2168-4790
Publication Date
January 1, 1996
Volume
31
Issue
4
Start / End Page
1145 / 1147